People In Brief
This article was originally published in The Gray Sheet
Executive Summary
AGA Medical CEO and IPO: Structural heart defect devices firm names a new CEO June 20 and on the same day files with the U.S. Securities and Exchange Commission for an initial public stock offering to raise up to $200 million. Chief Operating Officer John Barr is appointed president and CEO to replace Frank Gougeon, who co-founded the company with Kurt Amplatz in 1995. AGA says that Gougeon has decided to transition from day-to-day company oversight to an expanded role in long-term strategic planning. He will remain a member of the company's board and will chair a new corporate development committee